Working with an OI mouse model and using adeno-associated virus (AAV) for delivery purposes, Yang et al. carried out a CRISPR/Cas9, homology-directed repair approach to correct OI-causing Col1a2 mutations in vivo, and they reported an amelioration of the animal phenotypes [233]. The gene discussed is COL1A2; the disease is osteogenesis imperfecta.